Nuhn, P., Bolenz, C., & Hohenfellner, M. (2012). External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder. European journal of surgical oncology, 38(7), .
Chicago-Zitierstil (17. Ausg.)Nuhn, Philipp, Christian Bolenz, und Markus Hohenfellner. "External Validation of Disease-free Survival at 2 or 3 Years as a Surrogate and New Primary Endpoint for Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder." European Journal of Surgical Oncology 38, no. 7 (2012).
MLA-Zitierstil (9. Ausg.)Nuhn, Philipp, et al. "External Validation of Disease-free Survival at 2 or 3 Years as a Surrogate and New Primary Endpoint for Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder." European Journal of Surgical Oncology, vol. 38, no. 7, 2012.